The Treatment Resistant Depression Market is estimated to be valued at US$1,180.0 Mn in 2022 and is expected to exhibit a CAGR of 3.4% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Treatment Resistant Depression market refers to the segment of the pharmaceutical industry that focuses on developing therapies for...